The ACVR1 gene gives cells instructions for a receptor, a surface protein that passes along growth signals that guide bone and tissue development. This gene plays an important role in keeping those signals balanced. Certain harmful variants can make the signal too active, leading to fibrodysplasia ossificans progressiva, a rare condition in which extra bone forms in muscles, tendons, and ligaments and can limit movement. Some people with this condition are also born with unusually shaped big toes.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes carry the code for proteins, which do much of the cell’s work. Others mainly direct when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, and medications. More detail on this topic is available in the LearnHub.
Overview
ACVR1Gene function
What if the gene works
The ACVR1 gene helps cells receive growth signals, especially from bone morphogenetic proteins. This supports normal bone and cartilage development and helps guide tissue growth and repair.
Risk
What if the gene does not work
Changes in the ACVR1 gene can cause fibrodysplasia ossificans progressiva, where soft tissues gradually turn into bone, often with malformed big toes; milder or severe variants can affect timing and severity. Somatic variants are also linked to some brain tumors.
Treatment
What does that mean for your treatment
For a pathogenic variant in the ACVR1 gene, treatment may include palovarotene to reduce new abnormal bone formation. Its use depends on age and growth status because it can affect growing bones, so children need close specialist monitoring. Management also aims to reduce flare triggers, including trauma and intramuscular injections.
Gene function
What if the gene works
From early development through adult life, your cells use the ACVR1 gene to respond to growth signals. These signals help coordinate how tissues form, especially in bone and cartilage. This is part of how the ACVR1 gene helps build and maintain bone through normal cell communication.
The ACVR1 gene makes a receptor that sits on the cell surface and listens for bone morphogenetic protein, or BMP, signals. When those signals arrive, it passes the message inward so the cell can respond in an organized way.
After a signal is received, the ACVR1 gene helps switch on SMAD proteins, which are internal messengers. These messengers carry instructions to the nucleus, the cell’s control center, so the right genes can be used at the right time.
In bones and cartilage, ACVR1 signaling helps cells know when to grow, mature, and settle into their roles. This steady guidance supports normal skeletal development and ongoing bone maintenance.
During early growth, signals through the ACVR1 gene help tissues form in the right place and sequence. This supports the body plan as the skeleton and other structures take shape.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, such as variation in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ACVR1 gene usually make its receptor too active, so cells receive growth and bone forming signals at the wrong time. This explains how variants influence the ACVR1 gene's function: some changes keep the receptor switched on, while others make it respond abnormally to activin A, a body signal it should mostly ignore. Different variants can cause milder or stronger overactivity, which may shape how early and how noticeably features linked to the ACVR1 gene appear.
How variants are linked to conditions
Variants in the ACVR1 gene are best known for causing fibrodysplasia ossificans progressiva, a rare condition in which extra bone forms in muscles, tendons, and other soft tissues. In practice, the clearest ACVR1 gene and fibrodysplasia ossificans progressiva link is a diagnosis-causing one, not just a risk trend. Some acquired ACVR1 variants have also been found in certain childhood brain tumors, but those tumor changes are different from inherited variants.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply contribute to natural human variation. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with a disease-causing change in the ACVR1 gene, the chance of developing fibrodysplasia ossificans progressiva is largely set by the gene change itself. Injuries, muscle trauma, surgery, and sometimes viral illnesses can trigger flare-ups and extra bone growth, so they can worsen the condition rather than change whether it occurs.
Inheritance of ACVR1 variants
ACVR1 gene variants linked to fibrodysplasia ossificans progressiva are inherited in an autosomal dominant pattern, which means a parent carrying the variant can pass it to a child with a 50% chance in each pregnancy. In many families, though, the ACVR1 inheritance pattern starts with a new (de novo) variant in the affected person rather than a variant inherited from either parent. Once a person carries a disease-causing ACVR1 variant, they can pass it on to sons or daughters.
What does my ACVR1 result mean for my family?
For ACVR1, the main family pattern is dominant, so a parent with the same disease-causing change can pass it to a child, and close relatives may also want to learn whether they carry it. At the same time, many people with ACVR1-related fibrodysplasia ossificans progressiva are the first in their family to have the change, so a parent is not always the source. If a parent does carry the same change, each child has a 50% chance of inheriting it.
Genetic information
Genetic testing
How you find out about variants
ACVR1 genetic testing usually uses a blood or saliva sample. In practice, ACVR1 genetic testing works by reading the ACVR1 gene with sequencing, sometimes as part of a multigene panel, to look for variants that can help confirm a condition linked to the ACVR1 gene.
When should I consider getting a genetic test?
Consider genetic testing for the ACVR1 gene if someone has a rare condition where bone forms in muscles and other soft tissues, known medically as fibrodysplasia ossificans progressiva. Testing can also help when a baby is born with unusually shaped big toes or there is a family history of this condition.
A genetic result is only one part of your health story
Genetic findings can be informative, but how much they explain varies based on the condition and the type of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, these results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment may work well for one person, seem less helpful for another, or cause more side effects in someone else. Part of the reason is that inherited differences can change how the body absorbs, breaks down, or responds to a drug, and these differences are common.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way people respond to medicines. It studies gene drug patterns to better explain why the same treatment may work differently from one person to another. For many drugs, genes can influence both how strongly a medicine works and how the body handles it. This information can support more informed, more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the ACVR1 gene
When should I seek medical advice?
There isn’t yet a broadly confirmed role for this gene in guiding medication choice or dose. Questions about medicines, side effects, or your overall health are best discussed with your doctor.
History
Throughout history, people described the striking pattern of extra bone forming in soft tissues, a condition now called fibrodysplasia ossificans progressiva. For many years, doctors recognized the condition by its unusual signs, especially malformed big toes present from birth and later episodes of painful swelling. A major turning point came in 2006, when researchers identified changes in the ACVR1 gene as the cause in most affected people. From these first observations, research expanded steadily. That discovery solved a long-standing medical puzzle and gave families a clearer explanation for a condition that had often been misunderstood. It also opened the door to more precise diagnosis and to research focused on targeted treatments.